RM335.95
by Oliver Gassmann
Out of stock
ISBN: 9783030097820Format: PaperbackTotal Pages: 680By: AzarPublisher: Lippincott Williams and WilkinsPublication Year: 2019Weight (kg): 1.66---------------Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.